Autophagy Against Tuberculosis and HIV
Autophagy Against Tuberculosis and HIV
批准号:
10570827
负责人:
VOJO P DERETIC
金额:
$73.7万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-03-01 至 2025-02-28
关键词:
AcuteAddressAnti-Bacterial AgentsAutophagocytosisCell membraneCellsCentral Nervous SystemChronicClinicalCytoplasmCytoprotectionDiabetes MellitusDimensionsDiseaseDisease OutbreaksDrug resistanceDrug resistant Mycobacteria TuberculosisEffectivenessEpidemicEquilibriumExcisionFailureFundingGoalsHIVHIV/AIDSHIV/TBHealthHomeostasisImmuneImpairmentInfectionInfectious Diseases ResearchInflammationInterventionKnowledgeLinezolidLinkLungMacrophageMalnutritionMembraneMeningeal TuberculosisMessenger RNAMetabolicMetabolic ControlMetabolismMulti-Drug ResistanceMycobacterium tuberculosisNational Institute of Allergy and Infectious DiseaseNatural ImmunityNerve DegenerationObesityOrganOutcomePathogenesisPathologicPatientsPatternPositron-Emission TomographyPredispositionProcessPublic HealthQuality ControlRecurrenceRegimenResearchRiskRisk FactorsRoleSystemTBK1 geneTestingTissuesTuberculosisX-Ray Computed Tomographyadaptive immunitybactericidechemotherapyco-infectionin vivointerestlatent infectionmouse modelneuropathologynovel therapeuticsnutritional approachpreventprogramsrepairedresponsestandard care
中文摘要
结核分枝杆菌(Mtb)感染的结果与宿主的免疫、代谢和组织有关
英文摘要
The outcome of Mycobacterium tuberculosis (Mtb) infection depends on host’s immune, metabolic and tissue-
protective responses. Autophagy is a process that contributes to all three aspects of protection against
tuberculosis (TB). The effectiveness or failure of autophagy and related processes is of direct relevance for
central issues in TB. These include collusion between tuberculosis and HIV, immunometabolism and
metabolic dysregulation in diabetes, tissue damage in the lung or other organs such as the central nervous
system, and chronic pulmonary impairment or acute conditions following completion of chemotherapy.
This project intends to define the role of autophagy and associated processes in active TB, TB latency, HIV-
TB interactions, cellular metabolism, and as a cell/tissue-protective mechanism. Specifically, in this renewal
application we will delineate how autophagy and related processes marshal metabolic and cytoprotective
responses against Mtb in active and latent infection. While defining these relationships in the context of TB,
we will uncover fundamental mechanisms of significance for diverse health and pathological states of both
basic and translational value in TB.
Based on our latest findings, we propose to focus on the endomembrane damage inflicted by Mtb in infected
macrophages, as a trigger of cascading immunopathological and immunometabolic changes in the host. We
refer to this set of cellular responses as membrane repair, removal and replacement (MERET). Autophagy is
a key aspect of MERET, but MERET also includes immunometabolic switching, of relevance for tissue
protection vs. pathogenesis, and for active TB disease vs. latency.
The specific aims are:
Aim 1 Define the in vivo role of key autophagy factors in protection against Mtb. This aim will focus on
the role of the sole integral membrane autophagy (ATG) factor, ATG9, as the ultimate test of the role of
autophagic membranes in protection against active or latent TB. We will use murine models of acute and
chronic Mtb infection to test whether autophagy prevents or favors transitions to latent infection.
Aim 2. Determine the roles of TBK1 and ATG9 during critical stages of autophagy. We will focus on
ATG9 and TBK1 and how these factors contribute to cytoplasmic homeostasis and protection against Mtb.
Points of HIV interference will be tested.
Aim 3, Define host cell responses to endomembrane damage associated with Mtb infection. We will
focus on endomembrane damage, an intriguing but poorly understood phenomenon occurring during Mtb
infection of macrophages. We will test the hypothesis that host cell membrane damage caused by Mtb is a
critical determinant of autophagic and immunometabolic control of TB.
期刊论文(46)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.addr.2016.01.016
发表时间:
2016-07-01
期刊:
Advanced drug delivery reviews
影响因子:
16.1
作者:
[Gupta A, Misra A, Deretic V]
通讯作者:
Deretic V
DOI:
10.1016/j.cell.2021.10.017
发表时间:
2021-11-24
期刊:
Cell
影响因子:
64.5
作者:
[Kumar S, Javed R, Mudd M, Pallikkuth S, Lidke KA, Jain A, Tangavelou K, Gudmundsson SR, Ye C, Rusten TE, Anonsen JH, Lystad AH, Claude-Taupin A, Simonsen A, Salemi M, Phinney B, Li J, Guo LW, Bradfute SB, Timmins GS, Eskelinen EL, Deretic V]
通讯作者:
Deretic V
DOI:
10.1016/j.devcel.2023.03.014
发表时间:
2023-04
期刊:
Developmental cell
影响因子:
11.8
作者:
[Fulong Wang;R. Peters;Jingyue Jia;M. Mudd;M. Salemi;Lee Allers;Ruheena Javed;Thabata Duque;M. Paddar;Einar S. Trosdal;B. Phinney;V. Deretic]
通讯作者:
Fulong Wang;R. Peters;Jingyue Jia;M. Mudd;M. Salemi;Lee Allers;Ruheena Javed;Thabata Duque;M. Paddar;Einar S. Trosdal;B. Phinney;V. Deretic
DOI:
10.1083/jcb.201503023
发表时间:
2015-09-14
期刊:
The Journal of cell biology
影响因子:
--
作者:
[Kimura T, Jain A, Choi SW, Mandell MA, Schroder K, Johansen T, Deretic V]
通讯作者:
Deretic V
DOI:
10.1038/ncomms9620
发表时间:
2015-10-27
期刊:
Nature communications
影响因子:
16.6
作者:
[Chauhan S, Ahmed Z, Bradfute SB, Arko-Mensah J, Mandell MA, Won Choi S, Kimura T, Blanchet F, Waller A, Mudd MH, Jiang S, Sklar L, Timmins GS, Maphis N, Bhaskar K, Piguet V, Deretic V]
通讯作者:
Deretic V
共 24 条
Autophagy, Inflammation and Metabolism (AIM) in Disease Center
-
批准号:9207186
-
项目类别:
-
资助金额:$245.71万
-
财政年份:2017
-
负责人:VOJO P DERETIC
-
依托单位:
AIM Administrative Core
-
批准号:10249117
-
项目类别:
-
资助金额:$70.63万
-
财政年份:2017
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy, Inflammation and Metabolism (AIM) in Disease Center
-
批准号:10249116
-
项目类别:
-
资助金额:$218.04万
-
财政年份:2017
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy-based HDT for tuberculosis
-
批准号:9150518
-
项目类别:
-
资助金额:$56.14万
-
财政年份:2015
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy Against Tuberculosis and HIV
-
批准号:9232996
-
项目类别:
-
资助金额:$65.82万
-
财政年份:2014
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy Against Tuberculosis and HIV
-
批准号:9769998
-
项目类别:
-
资助金额:$74.45万
-
财政年份:2014
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy Against Tuberculosis and HIV
-
批准号:10092897
-
项目类别:
-
资助金额:$74.45万
-
财政年份:2014
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy Against Tuberculosis and HIV
-
批准号:8707081
-
项目类别:
-
资助金额:$65.6万
-
财政年份:2014
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy Against Tuberculosis and HIV
-
批准号:9025642
-
项目类别:
-
资助金额:$65.75万
-
财政年份:2014
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy Against Tuberculosis and HIV
-
批准号:10357752
-
项目类别:
-
资助金额:$73.7万
-
财政年份:2014
-
负责人:VOJO P DERETIC
-
依托单位:
Gordon Research Conference on Autophagy series
-
批准号:8062113
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:VOJO P DERETIC
-
依托单位:
Gordon Research Conference on Autophagy series
-
批准号:7904694
-
项目类别:
-
资助金额:$1.55万
-
财政年份:2010
-
负责人:VOJO P DERETIC
-
依托单位:
Gordon Research Conference on Autophagy series
-
批准号:8239523
-
项目类别:
-
资助金额:$1.55万
-
财政年份:2010
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy and Crohn's Disease
-
批准号:7834330
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy and Crohn's Disease
-
批准号:7936210
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy in Tuberculosis
-
批准号:7329824
-
项目类别:
-
资助金额:$36.54万
-
财政年份:2006
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy in Tuberculosis
-
批准号:7192792
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2006
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy in Tuberculosis
-
批准号:7992442
-
项目类别:
-
资助金额:$35.82万
-
财政年份:2006
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy in Tuberculosis
-
批准号:7534373
-
项目类别:
-
资助金额:$36.54万
-
财政年份:2006
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy in Tuberculosis
-
批准号:7736807
-
项目类别:
-
资助金额:$36.18万
-
财政年份:2006
-
负责人:VOJO P DERETIC
-
依托单位:
海外基金